RUBICAN

"RNF20 and H2B ubiquitination: linking chromatin dynamics, transcriptional control and cancer"

 Coordinatore WEIZMANN INSTITUTE OF SCIENCE 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Israel [IL]
 Totale costo 2˙500˙000 €
 EC contributo 2˙500˙000 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2011-ADG_20110310
 Funding Scheme ERC-AG
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-01-01   -   2016-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    WEIZMANN INSTITUTE OF SCIENCE

 Organization address address: HERZL STREET 234
city: REHOVOT
postcode: 7610001

contact info
Titolo: Ms.
Nome: Gabi
Cognome: Bernstein
Email: send email
Telefono: +972 8 934 6728
Fax: +972 8 934 4165

IL (REHOVOT) hostInstitution 2˙500˙000.00
2    WEIZMANN INSTITUTE OF SCIENCE

 Organization address address: HERZL STREET 234
city: REHOVOT
postcode: 7610001

contact info
Titolo: Prof.
Nome: Moshe
Cognome: Oren
Email: send email
Telefono: +972 8 934 2358
Fax: +972 8 934 6004

IL (REHOVOT) hostInstitution 2˙500˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

rnf    models    differentiation    cancer    vitro    related    modifications    line    chip    studied    seq    chromatin    emphasis    explore    bub       cell      

 Obiettivo del progetto (Objective)

'Chromatin modifications play a major role in regulating genome function. Perturbations in such modifications can contribute to neoplastic processes. We will focus on a specific chromatin modification: histone H2B monoubiquitylation. The significance of monoubiquitylated H2B (H2Bub) will be studied by manipulating RNF20, the major E3 ubiquitin ligase responsible for H2B ubiquitylation as part of a heteromeric complex with RNF40. In one major line of research, we will assess the biochemistry of RNF20/H2Bub. The effects of RNF20/H2B on gene expression will be explored through identification of proteins that interact with H2Bub and through in vitro incorporation of H2Bub into nucleosomes. Effects of H2Bub on transcription elongation will be studied by a new high resolution ChIP-seq method (NET-seq). Based on recent ChIP-seq data, we will also explore links between H2B and regulation of splicing. Furthermore, we will investigate the regulatory crosstalk between H2Bub and microRNAs. The other major line of research will explore the biology of RNF20/H2Bub, with particular emphasis on cancer-related processes. This will be addressed through a combination of cell culture models and mouse models, including constitutive and conditional RNF20 knockout mice. The contribution of RNF20/H2Bub to various differentiation programs, with particular emphasis on embryonic stem cell differentiation, will also be investigated. In addition, we will study the impact of RNF20/H2Bub on NF-kB activity and on inflammatory responses; this will combine in vitro and in vivo systems, with emphasis on inflammation-related cancer. Finally, we will monitor changes in RNF20, RNF40 and H2Bub status in human tumors and investigate underlying mechanisms.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

SM-DNA-REPAIR (2008)

New single-molecule techniques and their application in the study of DNA break repair

Read More  

EUROEMP (2013)

Employment in Europe

Read More  

FRONTIERS OF RNAI (2008)

The role of RNA silencing in immunity and development in eukaryotes

Read More